Eisai

Eisai and Wren Therapeutics to collaborate for drug discovery for synucleinopathies

Read more

Drug makers, BMGF pledge to strive for global access to COVID-19 diagnostics, therapeutics and vaccines

Read more

Gilead gets approval for Jyseleca (filgotinib) in Japan for rheumatoid arthritis

Read more

US FDA declines to approve Merck and Eisai’s liver cancer combo therapy

Read more

Biogen and Eisai revive plans for Alzheimer’s drug, surprising market

Read more

Glenmark Pharmaceuticals receives tentative ANDA approval for Rufinamide tablets USP

Read more